Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Cash from Financing Activities: 2010-2024

Historic Cash from Financing Activities for China Pharma Holdings (CPHI) over the last 14 years, with Dec 2024 value amounting to $27,353.

  • China Pharma Holdings' Cash from Financing Activities fell 1885.97% to -$122,214 in Q3 2025 from the same period last year, while for Sep 2025 it was -$214,633, marking a year-over-year decrease of 521.44%. This contributed to the annual value of $27,353 for FY2024, which is 62.60% down from last year.
  • According to the latest figures from FY2024, China Pharma Holdings' Cash from Financing Activities is $27,353, which was down 62.60% from $73,145 recorded in FY2023.
  • In the past 5 years, China Pharma Holdings' Cash from Financing Activities registered a high of $4.6 million during FY2021, and its lowest value of -$1.8 million during FY2022.
  • Over the past 3 years, China Pharma Holdings' median Cash from Financing Activities value was $27,353 (recorded in 2024), while the average stood at -$556,503.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first surged by 636.61% in 2021, then tumbled by 138.50% in 2022.
  • Over the past 5 years, China Pharma Holdings' Cash from Financing Activities (Yearly) stood at $624,177 in 2020, then soared by 636.61% to $4.6 million in 2021, then tumbled by 138.50% to -$1.8 million in 2022, then soared by 104.13% to $73,145 in 2023, then crashed by 62.60% to $27,353 in 2024.